Page 30 - Read Online
P. 30

Cheng et al. Cancer Drug Resist. 2025;8:46                                       Page 23 of 28




               39.  Zhang C, Yin X, Hao L, et al. Integrin-targeted, activatable nanophototherapeutics for immune modulation: enhancing
                  photoimmunotherapy efficacy in prostate cancer through macrophage reprogramming. Aggregate. 2025;6:e70001. DOI
               40.  Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metabol.
                  2019;30:36-50. DOI PubMed
               41.  He Z, Zhang S. Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment. Front
                  Immunol. 2021;12:741305. DOI PubMed PMC
               42.  Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other
                  ischemic tissues. Blood. 2004;104:2224-34. DOI PubMed
               43.  Pyonteck SM, Akkari L, Schuhmacher AJ, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat
                  Med. 2013;19:1264-72. DOI PubMed PMC
               44.  Tripathi C, Tewari BN, Kanchan RK, et al. Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic
                  M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin. Oncotarget. 2014;5:5350-68. DOI
                  PubMed PMC
               45.  Ke X, Chen C, Song Y, et al. Hypoxia modifies the polarization of macrophages and their inflammatory microenvironment, and inhibits
                  malignant behavior in cancer cells. Oncol Lett. 2019;18:5871-8. DOI PubMed PMC
               46.  Pillai SR, Damaghi M, Marunaka Y, Spugnini EP, Fais S, Gillies RJ. Causes, consequences, and therapy of tumors acidosis. Cancer
                  Metastasis Rev. 2019;38:205-22. DOI PubMed PMC
               47.  Colegio OR, Chu N, Szabo AL, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature.
                  2014;513:559-63. DOI PubMed PMC
               48.  Zhao Y, Wang D, Xu T, et al. Bladder cancer cells re-educate TAMs through lactate shuttling in the microfluidic cancer
                  microenvironment. Oncotarget. 2015;6:39196-210. DOI PubMed PMC
               49.  Paolini L, Adam C, Beauvillain C, et al. Lactic acidosis together with GM-CSF and M-CSF induces human macrophages toward an
                  inflammatory protumor phenotype. Cancer Immunol Res. 2020;8:383-95. DOI PubMed
               50.  Zhao Y, Zhao B, Wang X, et al. Macrophage transcriptome modification induced by hypoxia and lactate. Exp Ther Med.
                  2019;18:4811-9. DOI PubMed PMC
               51.  Zhang L, Li S. Lactic acid promotes macrophage polarization through MCT-HIF1α signaling in gastric cancer. Exp Cell Res.
                  2020;388:111846. DOI PubMed
               52.  Bohn T, Rapp S, Luther N, et al. Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages.
                  Nat Immunol. 2018;19:1319-29. DOI PubMed
               53.  Chen P, Zuo H, Xiong H, et al. Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis.
                  Proc Natl Acad Sci U S A. 2017;114:580-5. DOI PubMed PMC
               54.  Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575-80. DOI
                  PubMed PMC
               55.  Wu JY, Huang TW, Hsieh YT, et al. Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate
                  receptor. Mol Cell. 2020;77:213-27.e5. DOI PubMed
               56.  Cheng S, Wu C, Tsai Y, et al. CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance
                  immunotherapy in hepatocellular carcinoma. J Control Release. 2025;379:967-81. DOI PubMed
               57.  Jiang M, Li X, Zhang J, et al. Dual inhibition of endoplasmic reticulum stress and oxidation stress manipulates the polarization of
                  macrophages under hypoxia to sensitize immunotherapy. ACS Nano. 2021;15:14522-34. DOI PubMed
               58.  Fu Y, Zhang Y, Zhang Y, et al. Nanoreactors with cascade catalytic activity reprogram the tumor microenvironment for enhanced
                  immunotherapy by synchronously regulating Treg and macrophage cells. ACS Appl Mater Interfaces. 2024;16:49053-68. DOI PubMed
               59.  Wang Y, Fan Y, Zhang X, et al. In situ production and precise release of bioactive GM-CSF and siRNA by engineered bacteria for
                  macrophage reprogramming in cancer immunotherapy. Biomaterials. 2025;317:123037. DOI PubMed
               60.  Huang R, Kang T, Chen S. The role of tumor-associated macrophages in tumor immune evasion. J Cancer Res Clin Oncol.
                  2024;150:5777. DOI PubMed PMC
               61.  Medvedeva GF, Kuzmina DO, Nuzhina J, Shtil AA, Dukhinova MS. How macrophages become transcriptionally dysregulated: a hidden
                  impact of antitumor therapy. Int J Mol Sci. 2021;22:2662. DOI PubMed PMC
               62.  Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed
                  Sci. 2019;26:78. DOI PubMed PMC
               63.  Li M, He L, Zhu J, Zhang P, Liang S. Targeting tumor-associated macrophages for cancer treatment. Cell Biosci. 2022;12:823. DOI
                  PubMed PMC
               64.  Xu B, Sun H, Song X, Liu Q, Jin W. Mapping the tumor microenvironment in TNBC and deep exploration for M1
                  macrophages-associated prognostic genes. Front Immunol. 2022;13:923481. DOI PubMed PMC
                                                           23
   25   26   27   28   29   30   31   32   33   34   35